UK Pharmaceutical Logistics Market Size
| Study Period | 2024 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 10.83 Billion |
| Market Size (2029) | USD 13.25 Billion |
| CAGR (2024 - 2029) | 4.12 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
UK Pharmaceutical Logistics Market Analysis
The UK Pharmaceutical Logistics Market size is estimated at USD 10.83 billion in 2024, and is expected to reach USD 13.25 billion by 2029, at a CAGR of 4.12% during the forecast period (2024-2029).
- The pharmaceutical sector in the United Kingdom plays a pivotal role. Key trends shaping this sector include an uptick in outsourced logistics operations, technological advancements in cold chain management, and a growing demand for biologics and temperature-sensitive medications, notably vaccines and monoclonal antibodies.
- The UK's Medicine and Healthcare products Regulatory Agency (MHRA) oversees the safety, quality, and efficacy of medicines, medical devices, and other healthcare products. Manufacturers must comply with MHRA regulations to legally introduce their products into the UK healthcare system. The agency also holds the authority to intervene in the marketing and supply of devices that fail to meet established standards.
- For instance, Mawdsleys, an MHRA-approved storage facility, provides a range of services including refrigerated storage, controlled drug storage, cytotoxic substance storage, and active substance storage. Additionally, they offer dedicated warehouses that cater to both medical device and OTC storage needs.
- In the UK, the pharmaceutical logistics market is witnessing a growing demand for efficient and cost-effective solutions, especially when it comes to handling temperature-sensitive products.
- Pharmaceutical producers in U.K. are increasingly prioritizing product sensitivity and quality. Factors such as the advancement of sophisticated biological medicines and the distribution of hormone treatments, vaccinations, and intricate proteins, all necessitating cold chain enhancements, have heightened the demand for temperature-controlled transportation and warehousing.
- Moreover, the surging demand for temperature-controlled logistics in pharmaceuticals and medical devices is propelling the growth of the healthcare logistics market. In the UK, the cold chain logistics market is witnessing expansion, driven by the increasing need for efficient services that safeguard the quality of pharmaceutical products.
UK Pharmaceutical Logistics Market Trends
Surge in Cold Chain Transport Demand Drives Market
The government's stringent regulations mandating precise temperature controls for temperature-sensitive pharmaceutical products are anticipated to drive segment expansion during the forecast period. For instance, in March 2024, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) emphasized the critical need to comply with regulations, especially concerning temperature-sensitive products. This rising demand for temperature-sensitive pharmaceuticals is a major driver of the cold chain logistics market.
Telematics is being used more frequently in cold-chain pharmaceutical logistics, which is assisting businesses in improving the productivity, connectivity, and security of cargo. Direct-to-patient delivery models are reshaping cold chain transportation. Pharmaceutical Logistics Insights reported in March 2024 that home delivery services for medications are on the rise, especially for chronic conditions that necessitate continuous treatment.
The hard chain companie's cold chain logistics services are laying the groundwork for a bright future in the field of temperature-controlled logistics in U.K.. The rise of supply chain businesses has been fueled by the development of cold chain logistics, which has preserved the product's quality while maintaining the safety of the drugs.
In conclusion, the increasing demand for temperature-sensitive pharmaceuticals, coupled with advancements in telematics and direct-to-patient delivery models, is driving significant growth in the cold chain logistics market. The sector is poised for continued expansion, ensuring the safe and efficient transport of critical pharmaceutical products.
Pharmaceutical Logistics Market Thrives Amidst Chemical Pharma Surge
In the UK, the rising intricacy of pharmaceutical products, especially those categorized under chemical pharma, is propelling market growth. These products demand meticulous handling and transportation protocols. As the landscape of chemical pharmaceuticals evolves, logistics providers are increasingly adopting specialized transportation and storage solutions to uphold product integrity across the supply chain. A testament to this growth, Tata Chemicals recently announced a significant move: its subsidiary, Tata Chemicals Europe (TCEL), is set to invest 60 million EUR (approximately USD 62.88 million ) in establishing a pharmaceutical-grade sodium bicarbonate plant in Northwich, UK, with an impressive capacity of 1,80,000 tonnes per annum as reported by Business Standard on November 2024.
Moreover, the adoption of real-time monitoring systems, telematics, and automation in warehouse management is enhancing the tracking of temperature-sensitive shipments. Alloga, for example, provides specialized cold chain storage solutions catering to diverse product temperature needs, encompassing aerosols, hazardous goods, and controlled drugs.
In conclusion, the UK pharmaceutical logistics market is experiencing significant growth driven by advancements in chemical pharmaceuticals and the integration of cutting-edge logistics technologies. This trend is expected to continue, fostering further innovations and investments in the sector.
UK Pharmaceutical Logistics Industry Overview
The market is highly fragmented, with many companies across the UK. Some of the top names in this industry include Vision Logistics, Alloga, Alliance Healthcare, Kammac, and DFS Worldwide. To maintain their position in the market, pharmaceutical logistics companies are continuously undertaking strategic initiatives such as mergers and acquisitions.
Moreover, pharmaceutical logistics companies are adopting technologies like telematics, remote sensing, and GPS/GIS integration for cargo transportation, ensuring customers receive safe and efficient services. For instance, Alloga leverages technology to seamlessly connect products, customers, purchase orders, receipts, work in progress, shipments, invoices, stock status changes, inventory transactions, and balances, among other elements.
UK Pharmaceutical Logistics Market Leaders
-
Vision Logistics
-
Alloga
-
Alliance Healthcare
-
Kammac
-
DFS Worldwide
*Disclaimer: Major Players sorted in no particular order
UK Pharmaceutical Logistics Market News
- June 2024: LONDON, UK – Clinigen, a global leader in pharmaceutical services, has announced its acquisition of Ascenian, a specialized global market access consultancy. The merger aims to expedite the delivery of life-saving treatments and innovative therapies to patients. This strategic move marks a pivotal step in Clinigen's journey to establish itself as a top-tier global provider of high-value services tailored for the pharmaceutical and biotechnology sectors.
- May 2024: Myonex has acquired Creapharm’s pharmaceutical services business, enhancing its offerings for pharmaceutical and biotech clients at both clinical and commercial stages. Now operating as "Creapharm, a Myonex company," the acquired services include Creapharm’s clinical packaging, distribution services, commercial packaging operations, and bioservices.
UK Pharmaceutical Logistics Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS AND DYNAMICS
4.1 Current Market Scenario
4.2 Market Drivers
4.2.1 Increased Demand for Pharmaceuticals
4.2.2 Government Support and Investments
4.3 Market Restraints
4.3.1 Regulatory Challenges
4.3.2 Supply Chain Disruptions
4.4 Market Oppurtunities
4.4.1 Expansion into Emerging Markets
4.4.2 Focus on Personalized Medicine
4.5 Industry Attractiveness - Porters Five Force's Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers/Consumers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitute Products
4.5.5 Intensity of Competitive Rivalry
4.6 Insights Into The 3PL Market in United Kingdom
4.7 Value Chain / Supply Chain Analysis
4.8 Impact of Geopolitics and Pandemic on the Market
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 Generic Drugs
5.1.2 Branded Drugs
5.2 By Operation
5.2.1 Cold Chain Transport
5.2.2 Non-cold Chain Transport
5.3 By Application
5.3.1 Biopharma
5.3.2 Chemical Pharma
5.4 By Transportation
5.4.1 Airways
5.4.2 Railways
5.4.3 Roadways
5.4.4 Seaways
6. COMPETITIVE LANDSCAPE
6.1 Market Concentration Overview
6.2 Company Profiles
6.2.1 Vision Logistics
6.2.2 Alloga
6.2.3 Alliance Healthcare
6.2.4 Kammac
6.2.5 DHL
6.2.6 DFS Worldwide
6.2.7 Forest Freight
6.2.8 Cool Cargo
6.2.9 Dynamic Medical Logistics
6.2.10 CDL Logistics Group
6.2.11 Circle Express UK*
- *List Not Exhaustive
7. FUTURE OF THE MARKET
8. APPENDIX
8.1 Macroeconomic Indicators (GDP Distribution, by Activity)
8.2 Economic Statistics - Transport and Storage Sector Contribution to Economy
8.3 External Trade Statistics - Exports and Imports by Product and by Country of Destination/Origin
UK Pharmaceutical Logistics Industry Segmentation
Pharmaceutical logistics involves manufacturing, processing, and shipping materials and resources. Pharmaceutical Logistics companies also undertake activities related to handling finished products for customers.
Transporting healthcare products requires sophisticated logistics to ensure the integrity of pharmaceutical shipments. This involves specialized equipment, dedicated storage facilities, standardized handling procedures, and strong collaboration among cold chain partners. Logistics companies play a crucial role in the operations of pharmaceutical firms.
The United Kingdom Pharmaceutical Logistics market is segmented by product (generic drugs, branded drugs), by mode of operation (cold chain transport, non-cold chain transport), by application (bio pharma, chemical pharma), by mode of transport (air, rail, road, and sea) The report offers market size and forecast for United Kingdom Pharmaceutical Logistics Market in value (USD) for all the above segments.
| By Product | |
| Generic Drugs | |
| Branded Drugs |
| By Operation | |
| Cold Chain Transport | |
| Non-cold Chain Transport |
| By Application | |
| Biopharma | |
| Chemical Pharma |
| By Transportation | |
| Airways | |
| Railways | |
| Roadways | |
| Seaways |
UK Pharmaceutical Logistics Market Research FAQs
How big is the UK Pharmaceutical Logistics Market?
The UK Pharmaceutical Logistics Market size is expected to reach USD 10.83 billion in 2024 and grow at a CAGR of 4.12% to reach USD 13.25 billion by 2029.
What is the current UK Pharmaceutical Logistics Market size?
In 2024, the UK Pharmaceutical Logistics Market size is expected to reach USD 10.83 billion.
Who are the key players in UK Pharmaceutical Logistics Market?
Vision Logistics, Alloga, Alliance Healthcare, Kammac and DFS Worldwide are the major companies operating in the UK Pharmaceutical Logistics Market.
What years does this UK Pharmaceutical Logistics Market cover, and what was the market size in 2023?
In 2023, the UK Pharmaceutical Logistics Market size was estimated at USD 10.38 billion. The report covers the UK Pharmaceutical Logistics Market historical market size for years: . The report also forecasts the UK Pharmaceutical Logistics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
UK Pharmaceutical Logistics Industry Report
Statistics for the 2024 UK Pharmaceutical Logistics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. UK Pharmaceutical Logistics analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
UK Pharmaceutical Logistics Market Report Snapshots
